RU2519215C2 - Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств - Google Patents

Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств Download PDF

Info

Publication number
RU2519215C2
RU2519215C2 RU2010122302/15A RU2010122302A RU2519215C2 RU 2519215 C2 RU2519215 C2 RU 2519215C2 RU 2010122302/15 A RU2010122302/15 A RU 2010122302/15A RU 2010122302 A RU2010122302 A RU 2010122302A RU 2519215 C2 RU2519215 C2 RU 2519215C2
Authority
RU
Russia
Prior art keywords
formula
compound
sodium
kidney
treatment
Prior art date
Application number
RU2010122302/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2010122302A (ru
Inventor
Венсан ПИШЕТТ
Франсуа ЛЕБЛОН
Муна ЛАГРАУИ
Лин Ганьон
Original Assignee
Прометик Байосайенсиз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Прометик Байосайенсиз Инк. filed Critical Прометик Байосайенсиз Инк.
Publication of RU2010122302A publication Critical patent/RU2010122302A/ru
Application granted granted Critical
Publication of RU2519215C2 publication Critical patent/RU2519215C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2010122302/15A 2007-11-02 2008-11-03 Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств RU2519215C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98509407P 2007-11-02 2007-11-02
US60/985.094 2007-11-02
PCT/CA2008/001930 WO2009055933A1 (en) 2007-11-02 2008-11-03 Medium-chain length fatty acids and glycerides as nephroprotection agents

Publications (2)

Publication Number Publication Date
RU2010122302A RU2010122302A (ru) 2011-12-10
RU2519215C2 true RU2519215C2 (ru) 2014-06-10

Family

ID=40590499

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010122302/15A RU2519215C2 (ru) 2007-11-02 2008-11-03 Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств

Country Status (19)

Country Link
US (1) US9532962B2 (https=)
EP (1) EP2299998B1 (https=)
JP (1) JP5575655B2 (https=)
KR (1) KR101601987B1 (https=)
CN (1) CN101878028A (https=)
AU (1) AU2008318196B2 (https=)
BR (1) BRPI0818310A8 (https=)
CA (1) CA2704286C (https=)
DK (1) DK2299998T3 (https=)
ES (1) ES2664594T3 (https=)
IL (1) IL205362A (https=)
MX (1) MX338513B (https=)
MY (1) MY151439A (https=)
NO (1) NO2299998T3 (https=)
NZ (1) NZ584981A (https=)
PT (1) PT2299998T (https=)
RU (1) RU2519215C2 (https=)
WO (1) WO2009055933A1 (https=)
ZA (1) ZA201003030B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011246434A (ja) * 2010-04-28 2011-12-08 Fancl Corp フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
RU2778505C1 (ru) * 2021-07-07 2022-08-22 Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" Пептид, обладающий нефропротекторным действием, фармацевтическая композиция на его основе и способ ее применения

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2427416E (pt) 2009-05-04 2016-06-15 Prometic Pharma Smt Ltd Compostos aromáticos substituídos e seus usos farmacêuticos
MX365807B (es) 2010-10-27 2019-06-14 Prometic Pharma Smt Ltd Compuestos y composiciones para el tratamiento del cáncer.
WO2013031729A1 (ja) * 2011-08-26 2013-03-07 国立大学法人大阪大学 糖尿病性心血管合併症の予防・治療剤
KR20130023583A (ko) * 2011-08-29 2013-03-08 아주대학교산학협력단 파골세포 형성 억제 효과가 있는 카프르산 및 이를 포함하는 약학적 조성물
JP6538043B2 (ja) * 2013-11-05 2019-07-03 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 腎機能を向上させるための方法及び組成物
WO2017074266A1 (en) * 2015-10-30 2017-05-04 National University Of Singapore Androgen biosynthesis inhibitor
CN105559071A (zh) * 2016-01-12 2016-05-11 刘保惠 一种适用于肾病的特殊医学用途配方食品及其制备方法
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
US11406616B2 (en) 2016-06-08 2022-08-09 Sunregen Healthcare Ag Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
RU2764630C2 (ru) * 2016-12-21 2022-01-19 Лиминал Байосайенсиз Лимитед Способы и композиции для предотвращения или минимизации эпителиально-мезенхимального перехода
WO2019082912A1 (ja) * 2017-10-27 2019-05-02 学校法人北里研究所 慢性腎臓病の予防又は治療剤
US20190240180A1 (en) * 2018-02-08 2019-08-08 Nestec Sa Mct-based nutrition blend for providing health benefits in companion animals
MA53188A1 (fr) 2018-10-11 2021-12-31 Basf As Composés aromatiques et leurs utilisations pharmaceutiques
CN109602012A (zh) * 2018-12-11 2019-04-12 李卫平 一种功能性低蛋白能量米及其制备方法
CN111184728B (zh) * 2020-02-20 2023-04-04 上海市儿童医院 海藻糖在肾病综合征中的应用
AU2023292465A1 (en) * 2022-06-15 2024-12-12 Hill's Pet Nutrition, Inc. Pet food compositions
JP2024176004A (ja) * 2023-06-07 2024-12-19 リファインホールディングス株式会社 小胞体ストレス抑制剤、慢性腎臓病疾患予防改善剤および食品
CN118592613B (zh) * 2024-08-05 2025-01-07 杭州康源食品科技有限公司 中链脂肪酸混合结构脂在改善膳食诱导的糖脂代谢紊乱中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083122A1 (en) * 2001-04-11 2002-10-24 Yeda Research And Development Co. Ltd. Fatty alcohols and fatty acid esters useful for treatment of inflammation
RU2213570C2 (ru) * 2001-08-22 2003-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4737384A (en) * 1985-11-01 1988-04-12 Allied Corporation Deposition of thin films using supercritical fluids
AU651758B2 (en) 1992-02-07 1994-07-28 Tsumura & Co. Side-effect alleviant
US6689700B1 (en) * 1999-11-02 2004-02-10 University Of Massachusetts Chemical fluid deposition method for the formation of metal and metal alloy films on patterned and unpatterned substrates
ES2234877T5 (es) 2000-06-20 2010-10-18 Nutrition Sciences Acidos grasos de cadena media utilizables como agentes antimicrobianos.
IL158322A0 (en) * 2001-04-18 2004-05-12 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US7030168B2 (en) * 2001-12-31 2006-04-18 Advanced Technology Materials, Inc. Supercritical fluid-assisted deposition of materials on semiconductor substrates
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
DK1592416T3 (da) 2003-02-07 2009-04-20 Prometic Biosciences Inc Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis
JP5214880B2 (ja) 2003-07-25 2013-06-19 プロメティック、バイオサイエンシーズ、インコーポレーテッド 中鎖脂肪酸の金属塩の製造
EP1940379A4 (en) 2005-09-30 2009-05-13 Jackson H M Found Military Med METHOD FOR THE TREATMENT OF HEMORRHAGIC SHOCKS AND ASSOCIATED DISEASES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083122A1 (en) * 2001-04-11 2002-10-24 Yeda Research And Development Co. Ltd. Fatty alcohols and fatty acid esters useful for treatment of inflammation
RU2213570C2 (ru) * 2001-08-22 2003-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011246434A (ja) * 2010-04-28 2011-12-08 Fancl Corp フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
RU2778505C1 (ru) * 2021-07-07 2022-08-22 Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" Пептид, обладающий нефропротекторным действием, фармацевтическая композиция на его основе и способ ее применения

Also Published As

Publication number Publication date
NO2299998T3 (https=) 2018-06-02
RU2010122302A (ru) 2011-12-10
JP5575655B2 (ja) 2014-08-20
MX2010004856A (es) 2010-06-30
CA2704286C (en) 2016-08-23
KR20100106958A (ko) 2010-10-04
EP2299998A4 (en) 2011-03-30
CN101878028A (zh) 2010-11-03
JP2011502174A (ja) 2011-01-20
ZA201003030B (en) 2011-02-23
AU2008318196A1 (en) 2009-05-07
MY151439A (en) 2014-05-30
ES2664594T3 (es) 2018-04-20
US20100286269A1 (en) 2010-11-11
IL205362A0 (en) 2010-12-30
BRPI0818310A8 (pt) 2017-12-26
DK2299998T3 (en) 2018-03-26
US9532962B2 (en) 2017-01-03
AU2008318196B2 (en) 2014-04-10
BRPI0818310A2 (pt) 2017-10-10
CA2704286A1 (en) 2009-05-07
IL205362A (en) 2015-01-29
NZ584981A (en) 2012-05-25
PT2299998T (pt) 2018-04-02
WO2009055933A1 (en) 2009-05-07
EP2299998A1 (en) 2011-03-30
KR101601987B1 (ko) 2016-03-09
MX338513B (es) 2016-04-20
EP2299998B1 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
RU2519215C2 (ru) Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств
ES2262741T3 (es) Uso de acidos grasos poliinsaturados para la prevencion de accidentes cardiovasculares importantes.
JP6267681B2 (ja) Ｃ１６：１ｎ７−パルミトレアートを含む組成物および方法
JPWO2010038796A1 (ja) Ｃ型肝炎治療剤
CN103945840A (zh) 糖尿病性心血管并发症的预防/治疗剂
US20240382512A1 (en) Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof
FR3061658A1 (fr) Composition pharmaceutique comprenant en tant que principe actif une combinaison de d-limoneme, de lupeol et du cinnamaldehyde et/ou du methylhydroxychalcone polymere et/ou du beta-sitosterol et/ou de
US20200352890A1 (en) Reversibly protected thiolated electrophilic fatty acids as prodrugs
WO2016181409A1 (en) Saroglitazar magnesium for the treatment of chylomicronemia syndrome -
EP2968246A1 (en) Omega-3 pentaenoic acid compositions and methods of use
JP7818752B2 (ja) 心臓病態の治療に使用するためのカンナビジオール組成物
US20140287004A1 (en) Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
HK1150125A (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
CN102125567A (zh) 一种用于预防和治疗动脉粥样硬化的药物组合物
WO2014130746A1 (en) Use of an omega-3 lipid-based emulsion for protecting human organs from ischemic injury
JP2022533603A (ja) １５－ＨＥＰＥおよび／または１５－ＨＥＴｒＥを含む組成物、ならびに心血管代謝性疾患、メタボリックシンドローム、および／または関連疾患を治療または予防する方法
TW201827047A (zh) 用於預防及/或治療惡病質的ω-3脂肪酸組合物
Belluzzi 16 Polyunsaturated Fatty Acids
AU2015202580A1 (en) Gemcabene and derivatives for treating pancreatitis
HK1197969A (en) Compositions and methods comprising c16:1n7-palmitoleate

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20161101

PD4A Correction of name of patent owner